Tuesday, January 11, 2022

Psychedelic Stock News: Awakn Life Sciences (OTCQB: AWKNF) Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use Disorder Trial

Psychedelic Stock News: Awakn Life Sciences (OTCQB: AWKNF) Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use Disorder Trial

No comments:

Post a Comment